Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case-control study.

Park DJ, Takahashi Y, Kang JH, Yim YR, Kim JE, Lee JW, Lee KE, Lee JK, Lee SS.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):54-60. Epub 2017 Mar 10.

PMID:
28339361
2.

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.

PLoS One. 2008 Oct 6;3(10):e3347. doi: 10.1371/journal.pone.0003347.

3.

Are patients with systemic lupus erythematosus at increased risk for fibromyalgia?

Staud R.

Curr Rheumatol Rep. 2006 Dec;8(6):430-5. Review.

PMID:
17092442
4.

Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?

Mader S, Jeganathan V, Arinuma Y, Fujieda Y, Dujmovic I, Drulovic J, Shimizu Y, Sakuma Y, Stern JNH, Aranow C, Mackay M, Yasuda S, Atsumi T, Hirohata S, Diamond B.

Arthritis Rheumatol. 2018 Feb;70(2):277-286. doi: 10.1002/art.40356. Epub 2018 Jan 9.

5.
6.

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.

Chang EH, Volpe BT, Mackay M, Aranow C, Watson P, Kowal C, Storbeck J, Mattis P, Berlin R, Chen H, Mader S, Huerta TS, Huerta PT, Diamond B.

EBioMedicine. 2015 May 30;2(7):755-64. doi: 10.1016/j.ebiom.2015.05.027. eCollection 2015 Jul.

7.

Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.

Ogawa E, Nagai T, Sakuma Y, Arinuma Y, Hirohata S.

Mod Rheumatol. 2016;26(3):377-83. doi: 10.3109/14397595.2015.1083163. Epub 2015 Oct 1.

PMID:
26429674
9.

Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.

Yang Y, Yuan C, Shen SQ, Wang XE, Mei QH, Jiang WQ, Huang Q.

Mediators Inflamm. 2017;2017:5047898. doi: 10.1155/2017/5047898. Epub 2017 Jan 5.

10.

Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.

Pradhan V, Patwardhan M, Rajadhyaksha A, Dhawale N, Ghosh K.

Rheumatol Int. 2015 Mar;35(3):541-5. doi: 10.1007/s00296-014-3114-z. Epub 2014 Aug 14.

PMID:
25119833
11.

Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.

Massardo L, Bravo-Zehnder M, Calderón J, Flores P, Padilla O, Aguirre JM, Scoriels L, González A.

Lupus. 2015 May;24(6):558-68. doi: 10.1177/0961203314555538. Epub 2014 Oct 15.

PMID:
25318968
12.

Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.

Wang J, Zhao Y, Zhang J, Lei H, Zhu G, Fu B.

Cell Biochem Biophys. 2014 Nov;70(2):1005-9. doi: 10.1007/s12013-014-0010-9.

PMID:
24845150
13.

Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus.

Sun XY, Shi J, Han L, Su Y, Li ZG.

J Clin Lab Anal. 2008;22(4):271-7. doi: 10.1002/jcla.20248.

PMID:
18634076
14.

Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.

Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.

Scand J Rheumatol. 2007 Nov-Dec;36(6):442-7.

PMID:
18092265
15.

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G.

J Neurol. 2014 Sep;261(9):1706-14. doi: 10.1007/s00415-014-7406-8. Epub 2014 Jun 21. Review.

16.

[Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].

Lu XY, Ye S, Wang Y, Guo L, Chen XX, Fan W, Wang XD, Gu YY, Bao CD, Liu Q.

Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2462-6. Chinese.

PMID:
17156673
17.

Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.

Wolfe F, Petri M, Alarcón GS, Goldman J, Chakravarty EF, Katz RS, Karlson EW.

J Rheumatol. 2009 Jan;36(1):82-8. doi: 10.3899/jrheum.080212.

18.

Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.

Magro-Checa C, Schaarenburg RA, Beaart HJ, Huizinga TW, Steup-Beekman GM, Trouw LA.

Lupus. 2016 Jul;25(8):878-88. doi: 10.1177/0961203316643170.

PMID:
27252265
19.

Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.

Fujieda Y, Mader S, Jeganathan V, Arinuma Y, Shimizu Y, Kato M, Oku K, Minami A, Shimizu C, Yasuda S, Atsumi T.

Int J Rheum Dis. 2019 Mar;22(3):443-448. doi: 10.1111/1756-185X.13392. Epub 2018 Oct 24.

PMID:
30358102
20.

Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.

Kozora E, West SG, Maier SF, Filley CM, Arciniegas DB, Brown M, Miller D, Grimm A, Zhang L.

J Neurol Sci. 2010 Aug 15;295(1-2):87-91. doi: 10.1016/j.jns.2010.04.016. Epub 2010 May 23.

Supplemental Content

Support Center